Loading...
Back to narrative

AMBU B: Dividend Initiation And Margin Outlook Will Support Future Upside

Expansion Of Single-use Endoscopy Will Improve Hospital Efficiency

AMBU B logo
AMBU B
AnalystConsensusTarget
Not Invested
Published 16 Dec 2024

Update shared on 05 Dec 2025

Previous
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-18.7%
7D
-0.5%

Analysts have modestly raised their price target on Ambu by DKK 0.00 to reflect a slightly higher discount rate and updated profitability assumptions, while maintaining largely unchanged views on long term growth and valuation multiples.

What's in the News

  • Ambu A/S announced an annual dividend of DKK 0.41 per share, payable on December 8, 2025, with ex-date December 4 and record date December 5, 2025 (Key Developments).
  • The company issued financial guidance for 2025/26, targeting organic growth of 10% to 13%, mainly from higher procedure volumes and continued single use device conversion (Key Developments).
  • For 2025/26, Ambu expects an EBIT margin of 12% to 14%, with an adjusted range of 14% to 16% when excluding approximately 2 percentage points of tariff related impact (Key Developments).
  • Ambu maintained its financial guidance for 2024/25, reiterating organic revenue growth of 12% to 14% for the period (Key Developments).

Valuation Changes

  • Fair Value: unchanged at DKK 115.59 per share, indicating no revision to the central equity valuation.
  • Discount Rate: unchanged at 5.80%, indicating no revision to the required return in the updated model.
  • Revenue Growth: effectively unchanged, remaining around 11.45% annually in the long term forecast.
  • Net Profit Margin: effectively unchanged at approximately 14.67%, suggesting stable profitability expectations.
  • Future P/E: unchanged at 29.81x, indicating no revision to the valuation multiple applied to forward earnings.

Have other thoughts on Ambu?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.